Biomed Realty Trust Stock Price, News & Analysis (NYSE:BMR)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Biomed Realty Trust (NYSE:BMR)

Biomed Realty Trust logoBioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Industry, Sector and Symbol:
  • Industry: Commercial REITs - NEC
  • Sub-Industry: Office REITs
  • Sector: Commercial REITs - NEC
  • Symbol: NYSE:BMR
  • CUSIP: 09063H10
  • Web:
  • Trailing EPS: $1.04
  • Net Margins: 18.98%
  • Return on Equity: 3.73%
  • Return on Assets: 2.07%

Frequently Asked Questions for Biomed Realty Trust (NYSE:BMR)

What is Biomed Realty Trust's stock symbol?

Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR."

How were Biomed Realty Trust's earnings last quarter?

Biomed Realty Trust Inc (NYSE:BMR) posted its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.04. The real estate investment trust earned $178.01 million during the quarter, compared to the consensus estimate of $167.08 million. Biomed Realty Trust had a net margin of 18.98% and a return on equity of 3.73%. Biomed Realty Trust's revenue was up 5.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.38 EPS. View Biomed Realty Trust's Earnings History.

Who are some of Biomed Realty Trust's key competitors?

Who are Biomed Realty Trust's key executives?

Biomed Realty Trust's management team includes the folowing people:

  • Greg N. Lubushkin, Chief Financial Officer (Age 62)
  • James R. Berens, President of Wexford Science & Technology (Age 61)
  • Jonathan Paul Klassen, Executive Vice President, General Counsel, Secretary (Age 39)
  • John P. Bonanno, Executive Vice President, Leasing & Development (Age 49)
  • Karen A. Sztraicher, Executive Vice President - Asset Management (Age 51)

How do I buy Biomed Realty Trust stock?

Shares of Biomed Realty Trust can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Biomed Realty Trust?

Biomed Realty Trust's mailing address is 17190 Bernardo Center Dr, SAN DIEGO, CA 92128-7030, United States. The real estate investment trust can be reached via phone at +1-858-4859840.

MarketBeat Community Rating for Biomed Realty Trust (NYSE BMR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  303
MarketBeat's community ratings are surveys of what our community members think about Biomed Realty Trust and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Biomed Realty Trust (NYSE:BMR)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Biomed Realty Trust (NYSE:BMR)

Price Target History for Biomed Realty Trust (NYSE:BMR)

Analysts' Ratings History for Biomed Realty Trust (NYSE:BMR)

DateFirmActionRatingPrice TargetImpact on Share PriceDetails
1/22/2016Canaccord GenuityReiterated RatingHoldN/AView Rating Details
(Data available from 11/18/2015 forward)


Earnings History and Estimates Chart for Biomed Realty Trust (NYSE:BMR)

Earnings by Quarter for Biomed Realty Trust (NYSE:BMR)

Earnings History by Quarter for Biomed Realty Trust (NYSE BMR)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/28/2015Q115$0.37$0.41$167.08 million$178.01 millionViewListenView Earnings Details
8/5/2014Q214$0.36$0.40$160.80 million$171.16 millionViewListenView Earnings Details
8/7/2013Q213$0.39$0.37$143.47 million$159.64 millionViewListenView Earnings Details
2/6/2013Q412$0.34$0.36$134.72 million$138.80 millionViewListenView Earnings Details
11/1/2012Q312$0.33$0.34$130.32 million$134.54 millionViewN/AView Earnings Details
8/1/2012$0.29$0.32ViewN/AView Earnings Details
8/3/2011$0.29$0.29ViewN/AView Earnings Details
5/5/2011$0.30$0.30ViewN/AView Earnings Details
2/7/2011$0.28$0.30ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Biomed Realty Trust (NYSE:BMR)

No earnings estimates for this company have been tracked by


Current Dividend Information for Biomed Realty Trust (NYSE:BMR)

Most Recent Dividend:10/15/2015
Annual Dividend:$1.04
Dividend Yield:Infinity
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:100.00% (Trailing 12 Months of Earnings)
Track Record:7 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Biomed Realty Trust (NYSE:BMR)

Dividend History by Quarter for Biomed Realty Trust (NYSE BMR)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Biomed Realty Trust (NYSE BMR)

Insider Trades by Quarter for Biomed Realty Trust (NYSE:BMR)
Insider Trades by Quarter for Biomed Realty Trust (NYSE:BMR)

Insider Trades by Quarter for Biomed Realty Trust (NYSE BMR)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2015John P BonannoEVPSell4,800$21.01$100,848.00View SEC Filing  
6/15/2015James R BerensInsiderSell2,000$19.99$39,980.00View SEC Filing  
6/15/2015John P BonannoEVPSell5,000$19.85$99,250.00View SEC Filing  
3/16/2015Margaret Faye WilsonDirectorBuy2,300$21.76$50,048.00View SEC Filing  
9/8/2014Stephen A WilleyCAOSell1,388$22.50$31,230.00View SEC Filing  
8/13/2014Alan D GoldCEOSell26,615$22.17$590,054.55View SEC Filing  
8/13/2014Matthew G McdevittVPSell16,000$22.01$352,160.00View SEC Filing  
6/3/2014Matthew G McdevittVPSell7,000$21.91$153,370.00View SEC Filing  
5/14/2014Alan GoldCEOSell25,000$21.18$529,500.00View SEC Filing  
5/12/2014Stephen WilleyCAOSell4,840$21.00$101,640.00View SEC Filing  
3/11/2014Stephen WilleyCAOSell7,931$20.25$160,602.75View SEC Filing  
2/11/2014Matthew McdevittVPSell60,000$20.28$1,216,800.00View SEC Filing  
11/23/2012Matthew G McdevittVPSell5,223$19.05$99,498.15View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Biomed Realty Trust (NYSE:BMR)

Latest Headlines for Biomed Realty Trust (NYSE BMR)


Social Media



Biomed Realty Trust (NYSE BMR) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.